Chelsea Therapeutics
Homepage http://www.chelsearx.com
LinkedIn Profile https://linkedin.com/company/che***erapeu***
HQ Location
United States , North Carolina, Charlotte3530 Toringdon Way Suite 200 Charlotte, NC 28277 United States
Chelsea Therapeutics was a biopharmaceutical company specializing in the development of innovative products that addressed important unmet medical needs or offered alternatives to existing treatments. Chelsea's novel medication, Northera™ (droxidopa) for symptomatic neurogenic orthostatic hypotension was approved by the FDA in February 2014. The company was acquired by Lundbeck in June 2014.
Pharmaceuticals and Medicine Manufacturing
The Drugs and Medicine industry involves research, development, manufacturing and distribution of pharmaceutical drugs and medicines. Companies in this field focus on preventing and treating illness using medicinal compounds and therapies.
Career Opportunities at Chelsea Therapeutics
Stay updated on the latest job openings by checking back regularly or by visiting the company's official career page.
No job listings currently found.
Details of Chelsea Therapeutics
Related Companies and Competitors
Access All Contact Details
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive to ensure that the information is accurate and up-to-date, we cannot guarantee its completeness or accuracy. We do not endorse or guarantee the products or services of any company or individual listed.
